S. Laidinen

发表

Preoperative Angiopoietin-2 Serum Levels: A Marker of Malignant Potential in Ovarian Neoplasms and Poor Prognosis in Epithelial Ovarian Cancer

V. Kosma, S. Ylä-Herttuala, S. Heinonen, 2010, International Journal of Gynecologic Cancer.

Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.

S. Ylä-Herttuala, V. Marjomäki, H. Karvinen, 2011, European heart journal.

Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling.

T. Tuomainen, S. Ylä-Herttuala, O. Vuolteenaho, 2014, Cardiovascular research.

LDLR–/–ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina

H. Uusitalo, S. Ylä-Herttuala, G. Kalesnykas, 2013, Molecular vision.

Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol‐rich and calcified atherosclerotic lesions

S. Ylä-Herttuala, S. Laidinen, I. Kholová, 2011, European journal of clinical investigation.

Peroxisome proliferator‐activated receptor‐γ coactivator 1 α1 induces a cardiac excitation–contraction coupling phenotype without metabolic remodelling

T. Tuomainen, S. Ylä-Herttuala, Heidi Hynynen, 2016, The Journal of physiology.

Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus‐ and adenovirus‐mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye

K. Airenne, H. Uusitalo, S. Ylä-Herttuala, 2009, The journal of gene medicine.

ErbB Signalling is a Potential Therapeutic Target for Vascular Lesions with Fibrous Component

P. Salminen, S. Ylä-Herttuala, M. Kaikkonen, 2022, bioRxiv.

Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction

S. Ylä-Herttuala, J. Laakkonen, T. Liimatainen, 2018, Scientific Reports.

Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs.

S. Ylä-Herttuala, O. Gröhn, T. Liimatainen, 2008, Cardiovascular research.

Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice

M. Turunen, S. Ylä-Herttuala, E. Gao, 2014, PloS one.

Improved endothelialization of small-diameter ePTFE vascular grafts through growth factor therapy

K. Alitalo, S. Ylä-Herttuala, J. Wadström, 2018, Vascular biology.

Improved endothelialization of small-diameter ePTFE grafts through growth factor therapy.

K. Alitalo, S. Ylä-Herttuala, J. Wadström, 2018, Vascular Biology.

Antiangiogenic gene therapy with soluble VEGF‐receptors ‐1, ‐2 and ‐3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma

Pasi I. Tuunanen, V. Kosma, K. Alitalo, 2012, International journal of cancer.

Quantification of myocardial infarct area based on TRAFFn relaxation time maps - comparison with cardiovascular magnetic resonance late gadolinium enhancement, T1ρ and T2 in vivo

T. Liimatainen, S. Laidinen, H. Laakso, 2018, Journal of Cardiovascular Magnetic Resonance.

The follow‐up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times

S. Ylä-Herttuala, T. Liimatainen, T. Heikura, 2018, NMR in biomedicine.

Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice

Seppo Ylä-Herttuala, Pasi A Karjalainen, Juha Hartikainen, 2015, Physiological reports.

15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A– and Placental Growth Factor–Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression

S. Ylä-Herttuala, M. Babu, T. Heikura, 2008, Circulation research.

Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes

H. Uusitalo, T. Paavonen, S. Ylä-Herttuala, 2009, British Journal of Ophthalmology.

Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes.

S. Ylä-Herttuala, G. Kalesnykas, M. Babu, 2009, Human gene therapy.

Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models

K. Alitalo, P. Saavalainen, S. Meri, 2023, Vaccine.

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.

Timo Liimatainen, Seppo Ylä-Herttuala, Henna Karvinen, 2008, JACC. Cardiovascular imaging.

Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance TRAFFn, T1ρ and T2 relaxation times

S. Ylä-Herttuala, T. Liimatainen, S. Laidinen, 2023, Scientific Reports.

S. Ylä-Herttuala, M. Babu, T. Heikura, 2008, Circulation research.

Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling.

T. Tuomainen, S. Ylä-Herttuala, O. Vuolteenaho, 2014, Cardiovascular research.

ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component

P. Salminen, M. Kaikkonen, J. Laakkonen, 2023, eLife.

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.

S. Ylä-Herttuala, O. Gröhn, T. Liimatainen, 2007, JACC. Cardiovascular imaging.